Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition

American Journal of Cancer Research

Volumn 5, Issue 6, 2015, Pages 2022-2034

  Li, Qingguo ^a,b   Wu, Jitao ^c   Wei, Ping ^a,b   Xu, Ye ^a,b   Zhuo, Changhua ^a,b   Wang, Yuwei ^a,b   Li, Dawei ^a,b   Cai, Sanjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Colon cancer; EMT; FOXC2; Metastasis; Prognostic factor

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SNAIL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL FEATURE; COLON CANCER; COLON METASTASIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TISSUE MICROARRAY;

EID: 85006184157     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T, Wu KC, Ng S, Leung SY, Makharia G, Chong VH, Ho KY, Brooks D, Lieberman DA and Chan FK. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008; 57: 1166-1176.
3. Byeon JS, Yang SK, Kim TI, Kim WH, Lau JY, Leung WK, Fujita R, Makharia GK, Abdullah M, Hilmi I, Sollano J, Yeoh KG, Wu DC, Chen MH, Kongkam P and Sung JJ. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc 2007; 65: 1015-1022.
4. Lei T, Chen WQ, Zhang SW, Lei TH, Ying Q, He ZY and Wang XH. [Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002]. Zhonghua Zhong Liu Za Zhi 2009; 31: 428-433.
5. de Krijger I, Mekenkamp LJ, Punt CJ and Nagtegaal ID. MicroRNAs in colorectal cancer metastasis. J Pathol 2011; 224: 438-447.
6. Lim SH, Becker TM, Chua W, Ng WL, de Souza P and Spring KJ. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer. J Clin Pathol 2014; 67: 848-53.
7. Huang C, Xie D, Cui J, Li Q, Gao Y and Xie K. FOXM1c promotes pancreatic cancer epithelial- to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system. Clin Cancer Res 2014; 20: 1477-1488.
8. Yang C, Chen H, Tan G, Gao W, Cheng L, Jiang X, Yu L and Tan Y. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett 2013; 340: 104-112.
9. Wei P, Zhang N, Wang Y, Li D, Wang L, Sun X, Shen C, Yang Y, Zhou X and Du X. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J Biol Sci 2015; 11: 186-198.
10. Xia L, Huang W, Tian D, Zhang L, Qi X, Chen Z, Shang X, Nie Y and Wu K. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. Hepatology 2014; 59: 958-973.
11. Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, Ethier SP, Miller F and Wu G. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res 2011; 71: 1292-1301.
12. Xia L, Huang W, Tian D, Zhu H, Qi X, Chen Z, Zhang Y, Hu H, Fan D, Nie Y and Wu K. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 2013; 57: 610-624.
13. Song Y, Washington MK and Crawford HC. Loss of FOXA1/2 is essential for the epithelial-tomesenchymal transition in pancreatic cancer. Cancer Res 2010; 70: 2115-2125.
14. Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y, Ai Q, Zhang P, Song EL, Huang QB, Fan Y and Zhang X. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasisfree survival of patients with clear cell renal cell carcinoma. Clin Cancer Res 2014; 20:1779-1790.
15. Kume T. Foxc2 transcription factor: a newly described regulator of angiogenesis. Trends Cardiovasc Med 2008; 18: 224-228.
16. Kriederman BM, Myloyde TL, Witte MH, Dagenais SL, Witte CL, Rennels M, Bernas MJ, Lynch MT, Erickson RP, Caulder MS, Miura N, Jackson D, Brooks BP and Glover TW. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum Mol Genet 2003; 12: 1179-1185.
17. Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM and Mani SA. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res 2013; 73: 1981-1992.
18. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL and Weinberg RA. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basallike breast cancers. Proc Natl Acad Sci U S A 2007; 104: 10069-10074.
19. Watanabe A, Suzuki H, Yokobori T, Altan B, Kubo N, Araki K, Wada S, Mochida Y, Sasaki S, Kashiwabara K, Hosouchi Y and Kuwano H. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis. Cancer Sci 2013; 104: 1427-1432.
20. Zhu JL, Song YX, Wang ZN, Gao P, Wang MX, Dong YL, Xing CZ and Xu HM. The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma. Histopathology 2013; 62: 1038-1048.
21. Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M. FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol 2011; 18: 535-542.
22. Li D, Peng Z, Tang H, Wei P, Kong X, Yan D, Huang F, Li Q, Le X and Xie K. KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res 2011; 17: 3558-3568.
23. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ and Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995; 55: 237-241.
24. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M and Hung MC. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-940.
25. Liu B, Han SM, Tang XY, Han L and Li CZ. Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells. Oncol Rep 2014; 31: 2545-2554.
26. Sasahira T, Ueda N, Yamamoto K, Kurihara M, Matsushima S, Bhawal UK, Kirita T and Kuniyasu H. Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma. PLoS One 2014; 9: e92534.
27. Li W, Fu X, Liu R, Wu C, Bai J, Xu Y, Zhao Y and Xu Y. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Oncol Res 2013; 21: 111-120.
28. Bachelder RE, Yoon SO, Franci C, de Herreros AG and Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelialmesenchymal transition. J Cell Biol 2005; 168:29-33.
29. Bellacosa A, Kumar CC, Di Cristofano A and Testa JR. Activation of AKT kinases in cancer:implications for therapeutic targeting. Adv Cancer Res 2005; 94: 29-86.
30. Larue L and Bellacosa A. Epithelial-mesenchymal transition in development and cancer:role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005; 24: 7443-7454.